| Literature DB >> 26672485 |
Zhiyong Song1, Long Liu2, Xiaoyu Wang3, Yongqiang Deng4, Qinggong Nian4, Guangchuan Wang3, Shunya Zhu4, Xiaofeng Li5, Hangyu Zhou1, Tao Jiang5, Xurong Xu6, Ruikang Tang6, Chengfeng Qin2.
Abstract
Conventional therapeutic monoclonal antibodies (mAbs) are invalid for intracellular viruses but by using in situ biomineralization treatment, they can be successfully delivered into cells to inhibit intracellular viral replication. This achievement significantly expands the applications of mAbs and provides a new intracellular strategy to control viral infections.Entities:
Mesh：
Substances：
Year: 2016 PMID： 26672485 DOI： 10.1039/c5cc09252c
Source DB: PubMed Journal: Chem Commun (Camb) ISSN： 1359-7345 Impact factor: 6.222